Pharmaceutical Industry
Page 28 of 100
HealthBiogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021

HealthCassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By Cristin Flanagan and BloombergJune 8, 2021

By Sy MukherjeeJune 7, 2021

HealthPresident Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021

By Markian Hawryluk and Kaiser Health NewsMay 24, 2021

HealthWill AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By Sy MukherjeeMay 19, 2021

By Rena Conti, Richard Frank and Leslie DachMay 12, 2021

By Markian Hawryluk and Kaiser Health NewsApril 29, 2021

FeaturesGoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
By Erika FryApril 29, 2021

By Sy MukherjeeApril 27, 2021

By Sy MukherjeeApril 26, 2021

By Sy Mukherjee and David Z. MorrisApril 23, 2021

By Sy Mukherjee and David Z. MorrisApril 22, 2021
Most Popular




